Navigation Links
ALT (GPT) Reagent

ProductsALT (GPT) Reagent
Company Hemagen Diagnostics, Inc.
Item ALT (GPT) Reagent
Features 
Description Intended for the quantitative determination of alanine aminotransferase activity in serum or plasma. Single vial, dry powder reagent. Pyridoxal Phosphate tablets must be purchased separately for conformity to IFCC method. Kinetic reaction. Wavelength: 340 nm. Linearity: 440 U/L at 30 C.
Info Hemagen Diagnostics, Inc.
Customer Service: (877) 262-5978
Web site: http://www.hemagen.com/

Related medicine products :

1. ALT (GPT) Liquidplus Reagent
2. ALT (GPT) + Starter Reagent
3. Infinity™ ALT (GPT) (Powder)
4. Infinity™ ALT (GPT) (Liquid)
5. Bilirubin Direct Reagent
6. Bilirubin Total Reagent
7. Direct Bilirubin Reagent
8. Total Bilirubin Reagent
9. BUN Liquidplus Reagent
10. BUN Rate Reagent
11. BUN Slow Rate Reagent
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:9/4/2015)... ... 04, 2015 , ... According to an article published September 1 ... nursing homes and assisted living facilities are receiving insufficient care that could actually be ... father was at one point close to death, not because of a medical condition, ...
(Date:9/4/2015)... ... 04, 2015 , ... Mile High Connects today releases “First and Last Mile ... for sidewalks, bike paths, and other vital supports severely limit access to public transportation ... of dollars to expand public transit, there’s very little support for safe and convenient ...
(Date:9/4/2015)... ... 04, 2015 , ... After wearing the same uniforms for six seasons, the ... an effort to assist the team, the Jones Agency, a locally owned insurance firm ... funds for the new uniforms. , As is so often the case with high ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... ... announces that CEREC technology is now available at CitiDent. CEREC is a newer ... In addition to saving time for patients by eliminating the need for multiple ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute ... number 9 nationwide by Doximity. Faculty, residents and staff are honored to have ... in the quality of our ophthalmology residency program. Our faculty places a high priority ...
Breaking Medicine News(10 mins):Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3
... seaweed and glow-in-the-dark biochemical agents may hold the ... cells to treat patients with severe peripheral arterial ... basic scientists and interventional radiologists at Johns Hopkins. ... in rabbits, Johns Hopkins scientists safely and successfully ...
... (ABI) Identifies Peripheral Arterial Disease Patients at High ... Score in 6,200-Person NHANES StudySAN DIEGO, Calif., March ... available screening tests--like the ankle brachial index (ABI)--along ... Risk Score--has the potential to prevent devastating heart ...
... Certification Underscores Lionbridge,s Market-Leading Translation Management Program ... 10 Lionbridge (Nasdaq: LIOX ... ISO 13485:2003 certification which verifies quality management ... expands Lionbridge,s dedicated Life Sciences program and ...
... NOVATO, Calif., March 10 BioMarin Pharmaceutical Inc. (Nasdaq: ... Vice President and Chief Financial Officer of BioMarin, will present ... Health Care Conference in Boston on Tuesday, March 17th, 2009 ... live audio webcast of the conference call via the investor ...
... , , TUESDAY, March 10 (HealthDay News) -- A comprehensive ... workload faced by physicians, according to researchers who examined ... Permanente health plan. , Among its features, the system ... instead of a traditional office visit. The system was ...
... Leukemia & Lymphoma Society(R)PRINCETON, N.J., March 10 ... has been treated in its Phase 2 multicenter, ... Injection versus intensive salvage therapy in adult patients ... leukemia in first relapse. As previously announced, ...
Cached Medicine News:Health News:Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease 2Health News:Simple Test Helps Predict Heart Attack Risk 2Health News:Simple Test Helps Predict Heart Attack Risk 3Health News:Simple Test Helps Predict Heart Attack Risk 4Health News:Lionbridge Receives ISO 13485:2003 Certification for Quality Management 2Health News:BioMarin to Present at the Cowen and Company 29th Annual Health Care Conference 2Health News:Electronic Communication May Be Boon to Doctors' Time 2Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 2Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 3Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 4
(Date:9/4/2015)... India , September 4, 2015 ... Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) ... Technology and by Product - Global Forecast to 2020", ... to reach USD 2.5 Billion by 2020, growing at ... 2015 to 2020. Browse 139 Tables ...
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gbd3bt/stability_testing ) ... of Pharmaceuticals (London, UK - December 2-3, 2015)" ... comprehensive two day seminar delegates will: - ... suitable for global arketing - Be able to ... and facilities - Know how to save resource ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2